Lv7
4080 积分 2023-10-05 加入
A Randomized Dose-Ranging Basket Trial Design with Enrichment for Dose Optimization
10天前
已完结
Pituitary adenylate cyclase-activating polypeptide signalling as a therapeutic target in migraine
16天前
已完结
Targeting PACAP: Beyond Migraine to Cluster, Menstrual, and Post-traumatic Headaches
20天前
已完结
Pharmacologic Characterization of ALD1910, a Potent Humanized Monoclonal Antibody against the Pituitary Adenylate Cyclase-Activating Peptide
20天前
已完结
LY3437943, a novel triple GIP, GLP-1, and glucagon receptor agonist in people with type 2 diabetes: a phase 1b, multicentre, double-blind, placebo-controlled, randomised, multiple-ascending dose trial
25天前
已完结
LY3437943, a novel triple GIP, GLP-1, and glucagon receptor agonist in people with type 2 diabetes: a phase 1b, multicentre, double-blind, placebo-controlled, randomised, multiple-ascending dose trial
25天前
已完结
LY3437943, a novel triple GIP, GLP-1, and glucagon receptor agonist in people with type 2 diabetes: a phase 1b, multicentre, double-blind, placebo-controlled, randomised, multiple-ascending dose trial
25天前
已完结
Congenital Factor XI Deficiency: An Update
25天前
已完结
Factor XI deficiency and its management
25天前
已完结
Global profiling of arginine reactivity and ligandability in the human proteome
1个月前
已完结
皖公网安备34019202002308
